Quick Summary
Covering the latest research from top Wall Street investment banks

Burberry Q1 27 Preview: Overweight Maintained, Recovery Story Still Appealing

Institution
Morgan Stanley
Date
2026-06-24
Authors
Grace Smalley, CFA, Natasha Bonnet, Edouard Aubin, Cedric Norest
Company
Burberry
Ticker
BRBY.L
Industry
Brands
Rating
Overweight
BullishLow confidenceThe report maintains an Overweight rating and positions Burberry as a compelling idiosyncratic turnaround story, with Q1 LFL expected slightly above consensus and medium-term margin recovery supported by top-line improvement and cost control.
AuthorsGrace Smalley, CFA, Natasha Bonnet, Edouard Aubin, Cedric Norest
Target price1,350p
CoverageChina、Asia-Pacific、Europe
Asset classesEquity
Business segmentsRetail、EMEIA、Americas、Greater China、Asia Pacific
Research firm divisions/subsidiariesMorgan Stanley(Other)、Morgan Stanley & Co. International plc(Other)

AI summary card

Burberry Q1 27 Preview: Overweight Maintained, Recovery Story Still Appealing

Morgan Stanley expects Burberry Q1 same-store sales growth of 5%, slightly above Visible Alpha consensus of 4.7%, and believes brand repositioning, cost control, and margin recovery remain the key medium-term themes.

Rating: Overweight; sector view: In-Line; target price: 1,350p; share price: 1,103p; the time frame is typically 12-18 months.
BurberryOverweightTop PickQ1 27 PreviewBrand RecoveryLuxurySame-Store Sales GrowthDCF Valuation
  • Q1 27 same-store sales are expected to grow 5%, in line with Q4 and slightly above Visible Alpha consensus of 4.7%.
  • Growth is expected mainly from improved conversion and higher units per transaction, offsetting continued pressure on industry footfall.
  • Regionally, EMEA is expected to slow to -4.5%, but strong performance in the Americas, Greater China, and Korea should offset the pressure.
  • FY27 adjusted EBIT is kept at £251m, assuming 5.6% same-store sales growth, a 50bp year-on-year gross margin improvement, and broadly flat operating expenses.
  • Target price 1,350p, Overweight rating, closing price 1,103p, implying about 22.4% upside.

Report interpretation

Overview

This report is Morgan Stanley's forward-looking update on Burberry's Q1 27 results, incorporating observations from this week's meetings in New York with the company's CEO and CFO. The report keeps forecasts unchanged and argues that Burberry remains in the early stages of brand transformation, with room for medium-term improvement in product, marketing, and distribution; revenue growth combined with cost control should support margin recovery.

Core views

The core view is that Burberry's Q1 same-store sales performance is likely to remain positive and slightly above consensus. Morgan Stanley expects Q1 LFL growth of 5%, driven mainly by better conversion and higher UPT, while the impact from average unit retail improves from a slight drag in FY26 to flat to slightly positive contribution. Regionally, EMEA is expected to slow due to tourism spending and Middle East market pressure, but the Americas, Greater China, and Korea should remain strong. FY27 adjusted EBIT stays at £251m, indicating that the analyst remains confident in the medium-term recovery path.

Analysis framework

The report combines earnings previews, regional same-store sales breakdowns, company model forecasts, Visible Alpha consensus comparisons, and DCF valuation. The short-term focus is on Q1 LFL, regional growth dispersion, and the impact on the next 12 months of EPS consensus; the medium-term focus is on brand momentum, revenue growth, gross margin improvement, operating expense control, and margin recovery.

Methodology notes

  • Earnings ForecastMorgan Stanley ModelWare

    Company model forecasts

    The report notes that, unless otherwise stated, metrics are based on the Morgan Stanley ModelWare framework; FY27 forecasts include sales, EBIT, EPS, valuation multiples, and free cash flow yield.

  • Valuation methodsDCF

    Discounted cash flow valuation

    The target price is derived using DCF valuation to reflect Burberry's single-brand profile, revenue growth opportunity, and long-term margin recovery potential; the report assumes a WACC of 10% and a terminal growth rate of 2.0%.

  • Consensus ComparisonVisible Alpha consensus

    Market consensus comparison

    The Q1 27 preview table compares Morgan Stanley forecasts with Visible Alpha consensus, for example Q1 same-store sales at MSe 5.0% versus VA 4.7%.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Burberry (BRBY.L) equity
    core coverage name
    Strengths
    The brand transformation is still early, leaving room for further improvement in product, marketing, and distribution; Q1 LFL is expected slightly above consensus; cost control supports margin recovery.
    Weaknesses
    EMEA is expected to slow further, with pressure from tourism spending and the Middle East market; industry footfall remains challenging.
    Comparison
    Morgan Stanley's Q1 LFL forecast is 5.0%, above Visible Alpha consensus of 4.7%; retail revenue forecast is £454m, above consensus of £452m.
    Risks
    Strategic momentum may fade; operating expenses required to sustain revenue growth may be higher than expected; if EMEA pressure spreads or other regions slow, the recovery path could be disrupted.

Key data

  • Stock RatingOverweightThe most positive stock rating in Morgan Stanley's relative rating system.
  • Sector ViewIn-LineThe Brands sector view is In-Line.
  • Target Price1,350pBased on DCF valuation.
  • Closing Price1,103pAs of 2026-06-22.
  • Implied Upsideabout 22.4%Calculated from the 1,350p target price and 1,103p closing price.
  • Q1 27 LFL Forecast5.0%Visible Alpha consensus is 4.7%, with MSe 32bps higher.
  • Q1 27 Retail Revenue Forecast£454mVisible Alpha consensus is £452m.
  • FY27 Adjusted EBIT Forecast£251mThe report says the estimate is unchanged.
  • FY27 Sales Revenue Forecast£2,544mFiscal year ending in March.
  • FY27 EPS Forecast36.8pOn a consensus-methodology basis.
  • EMEA Q1 LFL Forecast-4.5%Further slowdown from -2% in Q4.
  • Americas Q1 LFL Forecast13.0%Continues to strengthen from 10% in Q4.
  • Greater China Q1 LFL Forecast10.0%The report expects continued strength.
  • Korea Q1 LFL Forecast14.0%The report expects continued strength.

Impact & implications

If Q1 performance meets Morgan Stanley's forecasts, the report expects the impact on the next 12 months of consensus EPS to be broadly unchanged, while continuing to validate the durability of Burberry's brand recovery. Regionally, investors need to judge whether the EMEA tourism and Middle East pressure is only a short-term disturbance, and whether strength in the Americas, Greater China, and Korea can be sustained. Over the medium term, if revenue growth and cost control are delivered, margin recovery will be the key driver of valuation re-rating.

Risks

  • Strategic initiatives may lose momentum after the initial improvement.
  • The increase in operating expenses required to sustain revenue growth may be underestimated.
  • EMEA is expected to be affected by lower tourism spending and the Middle East market, weighing on regional growth by roughly 2 percentage points in Q1.
  • Luxury industry footfall remains under pressure, which may offset improvements in conversion and UPT.
  • If brand momentum falls short of expectations, margin recovery may be slower than the model assumes.

What to watch

  • Whether Q1 27 same-store sales reach or exceed 5.0%.
  • Whether the EMEA slowdown is mainly driven by short-term tourism and Middle East factors.
  • Whether the strong growth in the Americas, Greater China, and Korea can continue.
  • Whether AUR shifts from a slight FY26 drag to a flat to slightly positive contribution.
  • Whether the FY27 adjusted EBIT of £251m and the medium-term assumption of about 6% LFL growth need to be revised.
  • Whether cost control is sufficient to support gross margin and operating margin recovery.
  • Whether any new M&A rumors emerge and drive valuation re-rating.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins